MHC
Meyer Handelman Company Portfolio holdings
AUM
$3.19B
1-Year Est. Return
21.1%
1 Year Est. Return
+21.1%
AUM
$3.16B
AUM Growth
+$131M
(+4.3%)
Holding
220
Top Buys
| 1 | +$8.77M | |
| 2 | +$2.7M | |
| 3 | +$1.99M | |
| 4 |
Visa
V
|
+$1.98M |
| 5 |
Amazon
AMZN
|
+$1.69M |
Top Sells
| 1 | +$10.1M | |
| 2 | +$4.4M | |
| 3 | +$4.21M | |
| 4 |
Entergy
ETR
|
+$4.02M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2.36M |
Sector Composition
| 1 | Technology | 25.26% |
| 2 | Industrials | 17.46% |
| 3 | Consumer Staples | 12.04% |
| 4 | Healthcare | 12.03% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sysco
SYY
$37.7B
| $38.5M | 1.22% |
467,346
-9,578
|
|
||
27
Illinois Tool Works
ITW
$76.4B
| $38.4M | 1.22% |
147,362
-985
|
|
||
28
Amgen
AMGN
$178B
| $35.3M | 1.11% |
124,913
-3,881
|
|
||
29
Chevron
CVX
$333B
| $33.5M | 1.06% |
215,783
-683
|
|
||
30
PepsiCo
PEP
$200B
| $33M | 1.04% |
234,889
-2,640
|
|
||
31
Corning
GLW
$80.8B
| $32.9M | 1.04% |
401,032
-22,810
|
|
||
|
32
Visa
V
$633B
| $32.6M | 1.03% |
95,445
+5,801
|
|
||
33
Merck
MRK
$270B
| $31.7M | 1% |
377,173
+6,025
|
|
||
34
Pfizer
PFE
$146B
| $31.5M | 1% |
1,237,617
-42,830
|
|
||
35
McDonald's
MCD
$219B
| $30M | 0.95% |
98,809
-4,500
|
|
||
36
RTX Corp
RTX
$271B
| $29.4M | 0.93% |
175,541
-3,020
|
|
||
37
Alphabet (Google) Class A
GOOGL
$3.98T
| $28.5M | 0.9% |
117,281
+427
|
|
||
38
3M
MMM
$89.1B
| $27.5M | 0.87% |
177,523
-2,757
|
|
||
39
Texas Instruments
TXN
$174B
| $27M | 0.85% |
146,953
|
|
||
40
NVIDIA
NVDA
$4.53T
| $25.7M | 0.81% |
137,538
-809
|
|
||
41
Automatic Data Processing
ADP
$105B
| $25.1M | 0.79% |
85,584
+1,431
|
|
||
42
TJX Companies
TJX
$175B
| $24.4M | 0.77% |
168,955
-2,870
|
|
||
43
GE Vernova
GEV
$185B
| $23.8M | 0.75% |
38,737
-290
|
|
||
44
Johnson & Johnson
JNJ
$527B
| $22.3M | 0.7% |
120,209
-1,950
|
|
||
45
TE Connectivity
TEL
$70.9B
| $21.7M | 0.69% |
98,950
-2,420
|
|
||
46
Ingersoll Rand
IR
$34.8B
| $21.6M | 0.68% |
261,452
-4,941
|
|
||
|
47
Bristol-Myers Squibb
BMY
$113B
| $21.4M | 0.68% |
475,518
-52,438
|
|
||
48
Eli Lilly
LLY
$930B
| $21.3M | 0.67% |
27,852
-477
|
|
||
49
Omnicom Group
OMC
$25.1B
| $20.6M | 0.65% |
252,679
+16,680
|
|
||
50
CME Group
CME
$101B
| $19.3M | 0.61% |
71,549
+9,977
|
|